Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00040742 · ClinicalTrials.gov registry record · Phase 2
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
A Phase 2 study, sponsored by Gary Morrow.
- Completed
- Registry status
- Phase 2
- Development phase
- 745
- Enrollment target
NCT00040742 is a Phase 2 study that has completed, run by Gary Morrow. The registered enrollment target is 745 participants.
The verdict
NCT00040742, a Phase 2 study, has completed, sponsored by Gary Morrow.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 745 participants
- Enrollment target
Study Summary
RATIONALE: Ginger may help reduce or prevent nausea. It is not yet known if antiemetic drugs are more effective with or without ginger in treating nausea caused by chemotherapy. PURPOSE: This randomized phase II/III trial is studying giving antiemetic drugs together with ginger to see how well they work compared to antiemetic drugs alone in treating nausea in patients who are receiving chemotherapy for cancer.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT ginger
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 745 participants |
| Start Date | 2003-03 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00040742
The ClinicalTrials.gov registry entry for NCT00040742 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 745 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gary Morrow, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00040742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00040742 about?
NCT00040742 is a clinical study titled "Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer". RATIONALE: Ginger may help reduce or prevent nausea. It is not yet known if antiemetic drugs are more effective with or without ginger in treating nausea caused by chemotherapy. PURPOSE: This randomized phase II/III trial is studying giving antiemetic drugs together with ginger to see how well they...
What is the current status of trial NCT00040742?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 745 participants. The study started on 2003-03. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00040742?
The interventions under investigation include: placebo (OTHER), ginger (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00040742?
This trial is sponsored by Gary Morrow, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.